These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 33466393

  • 21. Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.
    Pandi P, Bulusu R, Kommineni N, Khan W, Singh M.
    Int J Pharm; 2020 Aug 30; 586():119560. PubMed ID: 32565285
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques.
    Zhang Z, Dong L, Guo J, Li L, Tian B, Zhao Q, Yang J.
    Expert Opin Drug Deliv; 2021 Feb 30; 18(2):249-264. PubMed ID: 33112679
    [Abstract] [Full Text] [Related]

  • 24. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L, Mann AKP, Liu Z, Milewski M, Zhang S, Ren J, Dewitt K, Hermans A, Cote A.
    Int J Pharm; 2019 Mar 25; 559():147-155. PubMed ID: 30654058
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D, Chauhan H, Atef E.
    J Pharm Sci; 2014 Nov 25; 103(11):3511-3523. PubMed ID: 25196860
    [Abstract] [Full Text] [Related]

  • 29. Review of industrially recognized polymers and manufacturing processes for amorphous solid dispersion based formulations.
    Saha SK, Joshi A, Singh R, Dubey K.
    Pharm Dev Technol; 2023 Sep 25; 28(7):678-696. PubMed ID: 37427544
    [Abstract] [Full Text] [Related]

  • 30. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP, Cao Y, Kowalski J, Serajuddin AT.
    Mol Pharm; 2008 Sep 25; 5(6):994-1002. PubMed ID: 19434852
    [Abstract] [Full Text] [Related]

  • 31. Molecular Simulation and Statistical Learning Methods toward Predicting Drug-Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design.
    Walden DM, Bundey Y, Jagarapu A, Antontsev V, Chakravarty K, Varshney J.
    Molecules; 2021 Jan 01; 26(1):. PubMed ID: 33401494
    [Abstract] [Full Text] [Related]

  • 32. Amorphous solid dispersions: a robust platform to address bioavailability challenges.
    Newman A, Nagapudi K, Wenslow R.
    Ther Deliv; 2015 Feb 01; 6(2):247-61. PubMed ID: 25690090
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Review: physical chemistry of solid dispersions.
    Janssens S, Van den Mooter G.
    J Pharm Pharmacol; 2009 Dec 01; 61(12):1571-86. PubMed ID: 19958579
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A rational approach towards development of amorphous solid dispersions: Experimental and computational techniques.
    Chakravarty P, Lubach JW, Hau J, Nagapudi K.
    Int J Pharm; 2017 Mar 15; 519(1-2):44-57. PubMed ID: 28063904
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.